3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10441 |
Azosemide
|
Na-K-Cl cotransporter | Membrane transporter/Ion channel |
Azosemide 是磺胺类环利尿剂和NKCC1抑制剂,对 hNKCC1A 和 NKCC1B 的IC50分别为 0.246 和 0.197 µM。 | |||
T35336 |
Furosemide sodium
Frusemide Sodium,Lasix |
Na-K-Cl cotransporter | Membrane transporter/Ion channel |
Furosemide sodium (Frusemide Sodium) 是 Na+/K+/2Cl- (NKCC),NKCC1 和 NKCC2 共转运蛋白的有效的和具有口服活性抑制剂。Furosemide sodium 也是 GABAA 受体拮抗剂,对含 α6 受体的选择性是含 α1 受体的 100 倍。Furosemide sodium 用作利尿试剂,用于充血性心力衰竭,高血压和水肿的研究。 | |||
T61713 |
Bumetanide sodium
|
||
Bumetanide sodium is a potent loop diuretic that acts as a blocker for the sodium-potassium-chloride cotransporter (NKCC). It selectively inhibits NKCC1 and NKCC2, with IC50 values of 0.68 μM and 4.0 μM for hNKCC1A and hNKCC2A, respectively [1] [2]. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3604 |
Sodium dichloroacetate
Sodium Dichloroacetate,DCA,BCA,bichloroacetic acid,二氯乙酸钠,Sodium dichloroacetate (DCA),二氯醋酸酯 |
Apoptosis; Dehydrogenase; Reactive Oxygen Species; PDK | Apoptosis; Immunology/Inflammation; Metabolism; NF-κB; PI3K/Akt/mTOR signaling |
Sodium dichloroacetate (BCA) 是癌细胞线粒体中的一种代谢调节剂,具有抗癌活性。它抑制丙酮酸脱氢酶激酶,从而导致肿瘤微环境中的乳酸减少。它增加活性氧的产生并促进癌细胞凋亡,还可作为NKCC 抑制剂。 |